Share this article
Third CRTCE Clinic effectively addresses the unmet need of depression and suicide
VANCOUVER, BC, Jan. 25, 2021 /PRNewswire/ - Champignon Brands Inc. (the Company ), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), Chairman and CEO Roger McIntyre today announced the opening of a new Canadian Rapid Treatment Center of Excellence (
CRTCE) clinic in Ottawa, Ontario. This third clinic joins the Mississauga and Toronto clinics (CRTCE Clinics) in addressing the unmet need of depression and suicide through novel ketamine therapy treatment. Over twenty clinical trials have demonstrated that ketamine and esketamine have rapid and robust antidepressant effects in patients that have failed to respond to conventional antidepressants. During the COVID-19 pandemic, the need for effective treatment has become exponentially critical, said Dr. Joshua Rosenblat, Medical Director, CRTCE. Ketamine treatment for depression is very difficult to access in Canada. This third clinic shoul